Secondary Polycythemia in Men Receiving Testosterone Therapy Increases Risk of Major Adverse Cardiovascular Events and Venous Thromboembolism in the First Year of Therapy-Reference-Cited by-同舟云学术

Secondary Polycythemia in Men Receiving Testosterone Therapy Increases Risk of Major Adverse Cardiovascular Events and Venous Thromboembolism in the First Year of Therapy

Published:2022-06 Issue:6 Volume:207 Page:1295-1301
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Ory Jesse¹²^ORCID,Nackeeran Sirpi³,Balaji Navin C.³,Hare Joshua M.⁴,Ramasamy and Ranjith¹

Affiliation:

1. University of Miami, Department of Urology, Miami, Florida

2. Dalhousie University, Department of Urology, Halifax, Nova Scotia, Canada

3. University of Miami Miller School of Medicine, Miami, Florida

4. University of Miami, Division of Cardiology, Department of Medicine, Interdisciplinary Stem Cell Institute, Miami, Florida

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Link

http://www.auajournals.org/doi/pdf/10.1097/JU.0000000000002437

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular disease and testosterone therapy in male hypogonadism;Annals of the New York Academy of Sciences;2024-09-07

2. Risk of erythrocytosis in transgender individuals undergoing testosterone therapy: a systematic review;Minerva Endocrinology;2024-07

3. Adult-onset testosterone deficiency: the usefulness of hormone replacement in reducing mortality in men with this common age-related condition;Exploration of Endocrine and Metabolic Diseases;2024-06-28

4. Rises in Hematocrit Are Associated With an Increased Risk of Major Adverse Cardiovascular Events in Men Starting Testosterone Therapy: A Retrospective Cohort Claims Database Analysis;Journal of Urology;2024-02

5. Re: Cardiovascular Safety of Testosterone-Replacement Therapy;European Urology;2024-02